Genetic diversity and neutral selection in Plasmodium vivax erythrocyte binding protein correlates with patient antigenicity

Plasmodium vivax is the most widespread and difficult to treat cause of human malaria. The development of vaccines against the blood stages of P. vivax remains a key objective for the control and elimination of vivax malaria. Erythrocyte binding-like (EBL) protein family members such as Duffy bindin...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Jin-Hee, Cho, Jee-Sun, Ong, Jessica J. Y., Park, Ji-Hoon, Nyunt, Myat Htut, Sutanto, Edwin, Trimarsanto, Hidayat, Petros, Beyene, Aseffa, Abraham, Getachew, Sisay, Sriprawat, Kanlaya, Anstey, Nicholas M., Grigg, Matthew J., Barber, Bridget E., William, Timothy, Qi, Gao, Liu, Yaobao, Pearson, Richard D., Auburn, Sarah, Price, Ric N., Nosten, Francois, Rénia, Laurent, Russell, Bruce, Han, Eun-Taek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347095/
https://www.ncbi.nlm.nih.gov/pubmed/32645098
http://dx.doi.org/10.1371/journal.pntd.0008202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347095/
https://www.ncbi.nlm.nih.gov/pubmed/32645098
http://dx.doi.org/10.1371/journal.pntd.0008202

Ejemplares similares